Table 1 Basic characteristics of the included literature.

From: The benefits of septoplasty for patients with deviated nasal septum and allergic rhinitis: a meta-analysis

Study ID

Experiment

Control

Follow-up time

(month)

Therapy

N

Men/

Women

Age

(Years)

Rhinorrhea

Nasal obstruction

Nasal itching

Sneezing

Therapy

N

Men/

Women

Age

(Years)

Rhinorrhea

Nasal obstruction

Nasal itching

Sneezing

Jin 2016 [20]

S

37

17/20

40.45 ± 1.74

NA

NA

NA

NA

INCS & OAH

37

18/19

41.53 ± 2.00

NA

NA

NA

NA

NA

Lan 2014 [21]

S&

INCS

30

NA

30.5

NA

NA

NA

NA

INCS,

IND & OAH

30

NA

30.5

NA

NA

NA

NA

12

Liu 2015 [22]

S

100

NA

32.8 ± 6.2

NA

NA

NA

NA

INCS & OAH

98

NA

32.8 ± 6.2

NA

NA

NA

NA

6

Liu 2019 [23]

S

42

28/14

40.71 ± 2.79

2.59 ± 0.24

2.58 ± 0.25

2.56 ± 0.21

2.78 ± 0.21

INCS

42

29/13

40.45 ± 2.71

2.64 ± 0.21

2.56 ± 0.24

2.53 ± 0.24

2.76 ± 0.24

NA

Luo 2018 [24]

S

36

18/18

41.25 ± 1.59

NA

NA

NA

NA

INCS & OAH

36

19/17

40.63 ± 1.98

NA

NA

NA

NA

NA

Song 2021 [25]

S

59

33/26

32.5 ± 3.0

NA

NA

NA

NA

INCS

59

31/28

34.8 ± 3.1

NA

NA

NA

NA

NA

Tian 2016 [26]

S

39

21/18

44.8 ± 5.8

NA

NA

NA

NA

INCS & OAH

39

20/19

44.7 ± 5.5

NA

NA

NA

NA

6

Wang 2020,1 [27]

S

40

23/17

40.69 ± 2.75

2.51 ± 0.25

2.56 ± 0.25

2.53 ± 0.24

2.62 ± 0.21

INCS

40

21/19

41.75 ± 2.81

2.56 ± 0.24

2.61 ± 0.24

2.53 ± 0.24

2.59 ± 0.23

6

Wang 2020,2 [28]

S

29

15/14

41.52 ± 4.81

NA

NA

NA

NA

INCS

29

16/13

40.07 ± 4.57

NA

NA

NA

NA

NA

Wang 2021 [29]

S

48

25/23

43.84 ± 8.62

2.58 ± 0.26

2.59 ± 0.26

2.61 ± 0.29

2.60 ± 0.28

INCS

48

26/22

42.96 ± 8.47

2.54 ± 0.32

2.57 ± 0.29

2.62 ± 0.28

2.58 ± 0.30

NA

Wu 2015 [30]

S&INCS

32

17/15

35.9 ± 12.1

NA

NA

NA

NA

INCS & OAH

32

18/14

36.5 ± 10.9

NA

NA

NA

NA

6

Yang 2019 [31]

S

67

43/24

45.15 ± 4.91

NA

NA

NA

NA

INCS & OAH

67

45/22

45.18 ± 5.17

NA

NA

NA

NA

NA

Yao 2017 [32]

S

58

30/28

34.8 ± 6.2

NA

NA

NA

NA

INCS,

IND & OAH

58

31/27

35.1 ± 6.3

NA

NA

NA

NA

NA

Zhong 2017 [33]

S&INCS

60

32/28

36.8 ± 2.1

NA

NA

NA

NA

INCS

60

34/26

36.5 ± 2.4

NA

NA

NA

NA

12

Zhu 2017 [34]

S&INCS

32

19/13

30.8 ± 1.23

NA

NA

NA

NA

INCS & OAH

32

16/16

31.8 ± 1.73

NA

NA

NA

NA

NA

  1. S: Septoplasty. INCS: Intranasal corticosteroid sprays.OAH: Oral antihistamine. IND: Intranasal decongestants.
  2. Specific Usage and Dosage: Intranasal corticosteroid sprays: Once or twice daily, two sprays per administration (Budesonide 128ug, Fluticasone propionate 100ug, Mometasone furoate 100ug), for one month. Oral Antihistamines: Once daily, with a dosage of 5 mg to 10 mg per administration, for one month. Intranasal Decongestants: Once or twice daily, to be administered two sprays per administration, for one week.